Literature DB >> 32690262

An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activators.

Jintong Du1, Wen Li2, Bo Liu3, Yingkai Zhang4, Jinming Yu1, Xuben Hou5, Hao Fang6.   

Abstract

Research interest in the development of histone deacetylase 8 (HDAC8) activators has substantially increased since loss-of-function HDAC8 mutations were found in patients with Cornelia de Lange syndrome (CdLS). A series of N-acetylthioureas (e.g., TM-2-51) have been identified as HDAC8-selective activators, among others; however, their activation mechanisms remain elusive. Herein, we performed molecular dynamics (MD) simulations and fragment-centric topographical mapping (FCTM) to investigate the mechanism of HDAC8 activation. Our results revealed that improper binding of the coumarin group of fluorescent substrates leads to the "flipping out" of catalytic residue Y306, which reduces the enzymatic activity of HDAC8 towards fluorescent substrates. A pocket between the coumarin group of the substrate and thed catalytic residue Y306 was filled with the activator TM-2-51, which not only enhanced binding between HDAC8 and the fluorescent substrate complex but also stabilized Y306 in a catalytically active conformation. Based on this newly proposed substrate-dependent activation mechanism, we performed structure-based virtual screening and successfully identified low-molecular-weight scaffolds as new HDAC8 activators.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Activator; HDAC8; Molecular dynamics simulation; Virtual screening

Mesh:

Substances:

Year:  2020        PMID: 32690262      PMCID: PMC7373817          DOI: 10.1016/j.bmc.2020.115607

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  41 in total

1.  Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation.

Authors:  Matthew A Deardorff; Maninder Kaur; Dinah Yaeger; Abhinav Rampuria; Sergey Korolev; Juan Pie; Concepcion Gil-Rodríguez; María Arnedo; Bart Loeys; Antonie D Kline; Meredith Wilson; Kaj Lillquist; Victoria Siu; Feliciano J Ramos; Antonio Musio; Laird S Jackson; Dale Dorsett; Ian D Krantz
Journal:  Am J Hum Genet       Date:  2007-01-17       Impact factor: 11.025

2.  Acetanilide and bromoacetyl-lysine derivatives as activators for human histone deacetylase 8.

Authors:  Yusif M Mukhtar; Yajun Huang; Jiajia Liu; Di Chen; Weiping Zheng
Journal:  Bioorg Med Chem Lett       Date:  2017-04-13       Impact factor: 2.823

3.  Histone deacetylase activators: N-acetylthioureas serve as highly potent and isozyme selective activators for human histone deacetylase-8 on a fluorescent substrate.

Authors:  Raushan K Singh; Tanmay Mandal; Narayanaganesh Balsubramanian; Tajae Viaene; Travis Leedahl; Nitesh Sule; Gregory Cook; D K Srivastava
Journal:  Bioorg Med Chem Lett       Date:  2011-08-04       Impact factor: 2.823

4.  The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.

Authors:  Jian Wu; Chengli Du; Zhen Lv; Chaofeng Ding; Jun Cheng; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

5.  SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.

Authors:  Michelle Pacholec; John E Bleasdale; Boris Chrunyk; David Cunningham; Declan Flynn; Robert S Garofalo; David Griffith; Matt Griffor; Pat Loulakis; Brandon Pabst; Xiayang Qiu; Brian Stockman; Venkataraman Thanabal; Alison Varghese; Jessica Ward; Jane Withka; Kay Ahn
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

Review 6.  HDAC8 substrates: Histones and beyond.

Authors:  Noah A Wolfson; Carol Ann Pitcairn; Carol A Fierke
Journal:  Biopolymers       Date:  2013-02       Impact factor: 2.505

7.  Histone deacetylase 8 is required for centrosome cohesion and influenza A virus entry.

Authors:  Yohei Yamauchi; Heithem Boukari; Indranil Banerjee; Ivo F Sbalzarini; Peter Horvath; Ari Helenius
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

8.  Biochemical and structural characterization of HDAC8 mutants associated with Cornelia de Lange syndrome spectrum disorders.

Authors:  Christophe Decroos; Nicolas H Christianson; Laura E Gullett; Christine M Bowman; Karen E Christianson; Matthew A Deardorff; David W Christianson
Journal:  Biochemistry       Date:  2015-10-14       Impact factor: 3.162

9.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born.

Authors:  Andreas W Götz; Mark J Williamson; Dong Xu; Duncan Poole; Scott Le Grand; Ross C Walker
Journal:  J Chem Theory Comput       Date:  2012-03-26       Impact factor: 6.006

10.  PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations.

Authors:  Todd J Dolinsky; Paul Czodrowski; Hui Li; Jens E Nielsen; Jan H Jensen; Gerhard Klebe; Nathan A Baker
Journal:  Nucleic Acids Res       Date:  2007-05-08       Impact factor: 16.971

View more
  2 in total

1.  Decreased proliferation of aged rat beta cells corresponds with enhanced expression of the cell cycle inhibitor p27KIP1.

Authors:  Talon J Aitken; Jacqueline E Crabtree; Daelin M Jensen; Kavan H Hess; Brennan R Leininger; Jeffery S Tessem
Journal:  Biol Cell       Date:  2021-09-27       Impact factor: 4.458

Review 2.  A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors.

Authors:  Anna Fontana; Ilaria Cursaro; Gabriele Carullo; Sandra Gemma; Stefania Butini; Giuseppe Campiani
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.